Literature DB >> 3770366

Prevalence and incidence of inflammatory bowel disease in family members.

B A Lashner, A A Evans, J B Kirsner, S B Hanauer.   

Abstract

To determine the risk of having or developing inflammatory bowel disease (IBD) in a family member of an IBD patient, a population of 245 IBD probands was randomly selected from the University of Chicago IBD Registry and their family history was elucidated by questionnaire and follow-up telephone call. One hundred seventy-nine (73%) probands responded to the questionnaire. There were no demographic distinctions between those eligible for the study, those who were complete responders, those who were nonresponders, and those with a positive family history of IBD. Fifty-four family members from 40 proband families (22%) had confirmed IBD. Prevalence of IBD in family members at the time of diagnosis of the proband was highest for parents (4.6%), siblings (2.6%), and children (1.9%). Grandparents, aunts and uncles, and first cousins had prevalence of IBD of less than 1%. Incident case frequency was determined by dividing the number of cases incident after the diagnosis of the proband by all those ever at risk. The incident case frequency was highest for siblings (1.9%), parents (1.0%), and children (1.0%). There was concordance noted for type of disease in the proband and the relative. No association could be discerned between the familial risk of IBD and gender, race, or religion of the proband. Despite a high occurrence rate of proband families with IBD, the specific risk to first, second, or third degree family members is low.

Entities:  

Mesh:

Year:  1986        PMID: 3770366     DOI: 10.1016/0016-5085(86)90193-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  25 in total

Review 1.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

2.  Familial cutaneous photosensitivity and colitis with lethal outcome.

Authors:  P Labrune; P Huguet; D Alagille; M Odievre
Journal:  J Med Genet       Date:  1991-02       Impact factor: 6.318

Review 3.  Recent epidemiology of ulcerative colitis and Crohn's disease.

Authors:  J F Mayberry
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

4.  Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease.

Authors:  I Naom; J Lee; D Ford; S J Bowman; J S Lanchbury; I Haris; S V Hodgson; D Easton; J Lennard-Jones; C G Mathew
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

5.  Familial aggregation of inflammatory bowel disease in a Mediterranean area.

Authors:  C Cipolla; A Magliocco; L Oliva; M Cottone
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

6.  Relationship between site of disease and familial occurrence in Crohn's disease.

Authors:  M Cottone; C Brignola; M Rosselli; L Oliva; C Belloli; C Cipolla; A Orlando; G De Simone; M R Aiala; R Di Mitri; G Gatto; A Buccellato
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

7.  Period and generation effects on mortality from idiopathic inflammatory bowel disease.

Authors:  A Sonnenberg; T R Koch
Journal:  Dig Dis Sci       Date:  1989-11       Impact factor: 3.199

Review 8.  Stem cell transplant in inflammatory bowel disease: a promising modality of treatment for a complicated disease course.

Authors:  George A Salem; George B Selby
Journal:  Stem Cell Investig       Date:  2017-11-29

9.  [Initial symptoms, extra-intestinal manifestations and course of pregnancy in chronic inflammatory bowel diseases].

Authors:  H C Rath; T Andus; I Caesar; J Schölmerich
Journal:  Med Klin (Munich)       Date:  1998-07-15

10.  Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis.

Authors:  M Orholm; L Iselius; T I Sørensen; P Munkholm; E Langholz; V Binder
Journal:  BMJ       Date:  1993-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.